Search

Your search keyword '"Cerbone, Luigi"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Cerbone, Luigi" Remove constraint Author: "Cerbone, Luigi"
45 results on '"Cerbone, Luigi"'

Search Results

1. Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status

4. Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report

5. Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors

6. Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream

12. Supplementary Tables S1-S11 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

13. Supplementary Figures S1-S24 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

14. Data from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

15. Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

16. Abstract 6570: Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer

17. Supplementary Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

18. Supplementary Figure from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals

19. Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

21. The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups and correlates with gut microbiota (GM) in patients with advanced renal cell carcinoma (RCC).

22. Abstract PR009: Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer

23. Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens

24. Combined Response of Advanced Cutaneous Squamous Cell Carcinoma and Renal Cell Carcinoma to Immunotherapy: A Case Report

26. Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer

28. Efficacy of first-line combination therapy in metastatic renal cell carcinoma (mRCC) patients (pts) with poor performance status (PS).

29. Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib

30. Durable response after immunotherapy discontinuation for delayed and severe immune-related adverse events: a case report

31. Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients

32. Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma

33. The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma

35. Association of cabozantinib residual concentration (Ctrough) and blood clearance (Cl/F) with toxicity (tox) and progressive disease (PD) in metastatic renal cell carcinoma (mRCC) patients (pts): Results from a monocentric pharmacokinetics (PK) study.

42. Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study.

43. Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund

44. The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

Catalog

Books, media, physical & digital resources